Tchort
Bluelight Crew
- Joined
- Mar 25, 2008
- Messages
- 2,392
http://www.clinicaltrials.gov/ct2/show/NCT00175357?term=opioid+dependance&recr=Open&rank=16
Included in the link are inclusion and exclusion criteria, and who to contact and how to get involved.
Some patients will be given Methadone, Methadone + IV Heroin, or Methadone + IV Hydromorphone.
It's the Phase III trial for the NAOMI project.
This is important for the future of a permanent prescription Heroin program in Canada. I am hopeful that someone here can get involved and benefit.
NAOMI's website:
http://www.naomistudy.ca/
The link at the top is all the info about the study and how to get involved.
The objective of this study is to determine whether the closely supervised provision of injectable, pharmaceutical-grade heroin (in combination with oral methadone) is more effective than methadone therapy alone in recruiting, retaining, and benefiting long-term heroin users who have not been helped by current standard treatment options.
This is a two-centre (Vancouver, Montreal) RCT involving a total of 235 volunteers. Eligible participants will be randomized to injectable heroin combined with oral methadone as desired (45%) versus oral methadone alone (45%). A subset of 10% will be randomized to injectable hydromorphone (Dilaudid™). Hydromorphone and heroin will be given in a double-blind fashion; the purpose is to permit validation of reported illicit use of heroin through urine testing in the hydromorphone group. Research visits will be conducted quarterly and will occur independently of treatment clinic visits. Incentives will be used to maintain research follow-up whether or not the subject is retained in treatment. The analysis will be under intent-to-treat. The primary outcomes of interest are 1) recruitment and retention in the study and 2) illicit drug use and criminal behavior (as determined by the Europ-ASI) at 12 months. Secondary outcomes are measures of social function (e.g., social integration and functioning, quality of life) and cost-benefit/effectiveness of the interventions.
Included in the link are inclusion and exclusion criteria, and who to contact and how to get involved.
Some patients will be given Methadone, Methadone + IV Heroin, or Methadone + IV Hydromorphone.
It's the Phase III trial for the NAOMI project.
This is important for the future of a permanent prescription Heroin program in Canada. I am hopeful that someone here can get involved and benefit.
NAOMI's website:
http://www.naomistudy.ca/
The link at the top is all the info about the study and how to get involved.
Last edited by a moderator: